Methods for determining human sperm quality

US9759728B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9759728-B2
Application numberUS-201414913856-A
CountryUS
Kind codeB2
Filing dateSep 4, 2014
Priority dateSep 5, 2013
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods and kits for determining the human sperm quality.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for assessing sperm fertility rate in an infertile or hypofertile subject or a subject with difficulty to conceive for more than one year, comprising the steps of: i) liquefying a semen sample obtained from said subject at 37° C. for 30 minutes, ii) isolating spermatozoa from said semen sample through a single-step density gradient centrifugation, iii) washing said isolated spermatozoa with tris-buffered saline, iv) homogenizing said isolated spermatozoa with a lysis buffer to obtain a spermatozoa protein lysate, v) measuring the expression level of one or both of a kinase anchoring protein 4 (AKAP4) and Hexokinase 1 in said protein lysate, and vi) comparing said measured expression level with a reference value, wherein detecting a differential in the expression of the one or both of AKAP4 and Hexokinase 1 between the sample and the reference value is indicative of sperm fertility rate. 2. The method according to claim 1 wherein said subject is classified as a normozoospermic subject. 3. The method according to claim 1 , wherein said tris-buffered saline comprises 0.1 mM of HCl, 100 mM of NaCl, and has a pH equal to 7.6. 4. The method according to claim 1 , wherein step v) is performed by analyzing said spermatozoa protein lysate obtained in step iv) in a 1D SDS-PAGE with blue staining, providing a numerical analysis of said blue stained gel, selecting protein bands between Low molecular weights 15 to 30 kDA and protein bands between High molecular weights 80 and 110 kDa, representing each band by a densitometric curve and calculating the area under the densitometric curve, and calculating a ratio between the area under the densitometric curve from Low molecular weight and High molecular weight band intensities. 5. The method according to claim 4 wherein a ratio between 1 to 2 is indicative of good sperm quality, and a ratio above 2 is indicative of bad sperm quality. 6. The method according to claim 3 , wherein step v) is performed by analyzing said spermatozoa protein lysate obtained in step iv) in a 1D SDS-PAGE with blue staining, providing a numerical analysis of said blue stained gel, selecting protein bands between Low molecular weights 15 to 30 kDA and protein bands between High molecular weights 80 and 110 kDa, representing each band by a densitometric curve and calculating the area under the densitometric curve, and calculating a ratio between the area under the densitometric curve from Low molecular weight and High molecular weight band intensities. 7. A method enabling an infertile or hypofertile subject or a subject with difficulty to conceive for more than one year to determine the most successful assisted-reproductive technology comprising the steps of: i) liquefying a semen sample obtained from said subject at 37° C. for 30 minutes, ii) isolating spermatozoa from said semen sample through a single-step density gradient centrifugation, iii) washing said isolated spermatozoa with tris-buffered saline, iv) homogenizing said isolated spermatozoa with a lysis buffer to obtain a spermatozoa protein lysate, v) measuring the expression level of one or both of AKAP4 and Hexokinase 1 in said protein lysate, and vi) comparing said measured expression level with a reference value, wherein detecting a differential in the expression of the one or both of AKAP4 and Hexokinase 1 between the sample and the reference value is indicative of a given assisted reproductive technology. 8. The method according to claim 7 , wherein step v) is performed by analyzing said spermatozoa protein lysate obtained in step iv) in a 1D SDS-PAGE with blue staining, providing a numerical analysis of said blue stained gel, selecting protein bands between Low molecular weights 15 to 30 kDA and protein bands between High molecular weights 80 and 110 kDa, representing each band by a densitometric curve and calculating the area under the densitometric curve, and calculating a ratio between the area under the densitometric curve from Low molecular weight and High molecular weight band intensities, wherein when said ratio is above 2 choosing intrauterine insemination (IUI) as an assisted-reproductive technology. 9. The method according to claim 7 , wherein said tris-buffered saline comprises 0.1 mM of HCl, 100 mM of NaCl and has a pH equal to 7.6. 10. The method according to claim 7 , wherein said subject is classified as a normozoospermic subject.

Assignees

Inventors

Classifications

  • G01N33/689Primary

    related to pregnancy or the gonads · CPC title

  • with a definite EC number (2.7.1.-) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9759728B2 cover?
The present invention relates generally to the fields of reproductive medicine. More specifically, the present invention relates to methods and kits for determining the human sperm quality.
Who is the assignee on this patent?
Inserm (Institut Nat De La Santé Et De La Rech Médicale, Université De Droit Et De La Santé De Lille 2, Centre Hospitalier Regional Univ Lille, and 2 more
What technology area does this patent fall under?
Primary CPC classification G01N33/689. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).